Viridian Therapeutics, Inc. (FRA:1S1)
Germany · Delayed Price · Currency is EUR 27.68
+0.67 (2.48%)
Last updated: Dec 1, 2025, 8:06 AM CET
Viridian Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -301.97 | -269.95 | -237.73 | -129.87 | -79.41 | -110.72 | Upgrade |
Depreciation & Amortization | 0.86 | 1.24 | 1.32 | 0.76 | 0.12 | 0.24 | Upgrade |
Other Amortization | - | - | - | - | - | 0.28 | Upgrade |
Loss (Gain) From Sale of Assets | - | 0.45 | 0 | - | 0.08 | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 65.99 | Upgrade |
Loss (Gain) From Sale of Investments | -8.21 | -15.66 | -11.49 | -0.21 | 0.96 | 0.06 | Upgrade |
Stock-Based Compensation | 41.29 | 42.15 | 67.17 | 19.77 | 14.47 | 3.65 | Upgrade |
Other Operating Activities | -0.08 | -0.15 | 5.98 | -0.24 | 7.49 | 6.3 | Upgrade |
Change in Accounts Receivable | -69.9 | 0.1 | - | 0.35 | -0.45 | - | Upgrade |
Change in Accounts Payable | 4.02 | -0.07 | -12.04 | 11.52 | 1.66 | -0.43 | Upgrade |
Change in Unearned Revenue | -0.29 | -0.29 | -0.29 | -0.29 | 0.64 | - | Upgrade |
Change in Other Net Operating Assets | 8.31 | 9.86 | 2.9 | 4.38 | -0.12 | 4.85 | Upgrade |
Operating Cash Flow | -325.97 | -232.32 | -184.17 | -93.84 | -54.58 | -29.78 | Upgrade |
Capital Expenditures | -0.37 | -0.51 | -0.9 | -0.8 | -0.34 | -0.04 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | 0.08 | - | Upgrade |
Cash Acquisitions | - | - | - | - | - | 29.37 | Upgrade |
Investment in Securities | 239.31 | -228.14 | -93.35 | -114.33 | -74.03 | -79.81 | Upgrade |
Other Investing Activities | - | - | - | - | - | -0 | Upgrade |
Investing Cash Flow | 238.94 | -228.65 | -94.25 | -115.13 | -74.29 | -50.48 | Upgrade |
Long-Term Debt Issued | - | - | 15 | 5 | - | 1.73 | Upgrade |
Total Debt Issued | - | - | 15 | 5 | - | 1.73 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | - | -10.29 | Upgrade |
Net Debt Issued (Repaid) | - | - | 15 | 5 | - | -8.57 | Upgrade |
Issuance of Common Stock | 58.08 | 459.68 | 146.79 | 295.75 | 116.59 | 25.1 | Upgrade |
Repurchase of Common Stock | - | - | - | - | - | -0.04 | Upgrade |
Other Financing Activities | -1.73 | -26.94 | -12.32 | -22.51 | -8.28 | -6.18 | Upgrade |
Financing Cash Flow | 56.36 | 457.74 | 225.67 | 322.24 | 125.28 | 101.31 | Upgrade |
Net Cash Flow | -30.67 | -3.23 | -52.75 | 113.28 | -3.6 | 21.05 | Upgrade |
Free Cash Flow | -326.34 | -232.83 | -185.07 | -94.64 | -54.92 | -29.82 | Upgrade |
Free Cash Flow Margin | -461.00% | -77096.03% | -58938.85% | -5340.58% | -1853.49% | -2840.10% | Upgrade |
Free Cash Flow Per Share | -4.02 | -3.43 | -4.13 | -2.95 | -4.61 | -8.38 | Upgrade |
Cash Interest Paid | 1.82 | 1.82 | 0.89 | 0.29 | - | 0.27 | Upgrade |
Levered Free Cash Flow | -222.89 | -136.12 | -102.02 | -48.33 | -33.91 | -16.58 | Upgrade |
Unlevered Free Cash Flow | -220.99 | -134.22 | -100.86 | -48.02 | -33.91 | -16.55 | Upgrade |
Change in Working Capital | -57.86 | 9.6 | -9.43 | 15.96 | 1.72 | 4.43 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.